Cart
sales@molnova.com
GSK-3117391
CAS No. 1018673-42-1
GSK-3117391( CHR-5154 | GSK3117391 | CHR5154 )
Catalog No. M10089 CAS No. 1018673-42-1
GSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 93 | In Stock |
|
| 5MG | 85 | In Stock |
|
| 10MG | 140 | In Stock |
|
| 25MG | 282 | In Stock |
|
| 50MG | 445 | In Stock |
|
| 100MG | 714 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGSK-3117391
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor.
-
DescriptionGSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor, has the potential to complement existing therapies in the treatment of chronic inflammatory disorders such as rheumatoid arthritis.Rheumatoid Arthritis Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsCHR-5154 | GSK3117391 | CHR5154
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC
-
Research AreaInflammation/Immunology
-
IndicationRheumatoid Arthritis
Chemical Information
-
CAS Number1018673-42-1
-
Formula Weight389.496
-
Molecular FormulaC21H31N3O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (123.91 mM)
-
SMILESO=C(OC1CCCC1)[C@H](C2CCCCC2)NCC3=CC=C(CCC(NO)=O)N=C3
-
Chemical Namecyclopentyl (S)-2-cyclohexyl-2-((6-(3-(hydroxyamino)-3-oxopropyl)pyridin-3-yl)amino)acetate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
BRD9757
BRD9757 is a potent, selective HDAC6 inhibitor with IC50 of 8 nM.
-
BML-210
A novel histone deacetylase (HDAC) inhibitor that induces Ac-histone in A549 cells with EC50 of 181 uM.
-
1-Naphthohydroxamic ...
1-Naphthohydroxamic acid (Compound 2) is a potent and selective HDAC8 inhibitor with an IC50 of 14 μM, and it is more selectively for HDAC8 than class I HDAC1 and class II HDAC6 (IC50 >100 μM).
